MariMed insider filing: 111,112 RSUs vested; 32,612 shares withheld
Rhea-AI Filing Summary
MariMed (MRMD) insider update: Chief Operating Officer Timothy Shaw reported routine equity transactions on 10/27/2025. He converted 111,112 restricted stock units into common stock (Code M; price $0), then had 32,612 shares withheld to cover taxes (Code F) at $0.1579 per share. Following these transactions, Shaw beneficially owns 9,133,912 shares directly. He also has 2,000,000 shares held indirectly by the Shaw Family Trust. The RSUs were granted on October 27, 2022 and are now fully vested, with no unvested RSUs remaining under that grant.
Positive
- None.
Negative
- None.
Insights
Routine RSU vesting with tax withholding; neutral impact.
The filing shows an RSU vest (Code M) of 111,112 shares at $0, typical for time-based awards converting one-for-one into common stock. The subsequent tax event (Code F) withheld 32,612 shares at $0.1579 to satisfy withholding obligations, a standard non-cash settlement.
Post-transaction holdings are 9,133,912 shares direct and 2,000,000 indirect via a trust. This is administrative and does not signal new open-market buying or selling. Actual market impact depends on any future trades, which are not indicated in the excerpt.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units (RSU) | 111,112 | $0.00 | -- |
| Exercise | Common stock | 111,112 | $0.00 | -- |
| Tax Withholding | Common stock | 32,612 | $0.1579 | $5K |
| holding | Common stock | -- | -- | -- |
Footnotes (1)
- RSUs convert to shares of common stock on a one-for-one basis. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs. The Reporting Person's spouse is the trustee of the trust and the shares held in the trust are for the benefit of the Reporting Person's children. The trust is an irrevocable trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These RSUs were granted on October 27, 2022; there are no unvested RSUs remaining under this grant in accordance with the terms of an award agreement between the Issuer and the Reporting Person.